
Delia M. Ramirez
Examiner (ID: 17488, Phone: (571)272-0938 , Office: P/1652 )
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 1545 |
| Issued Applications | 838 |
| Pending Applications | 179 |
| Abandoned Applications | 542 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20316140
[patent_doc_number] => 12454684
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Methods using novel CPF1 mutations that enhance the DNA cleavage activity of
[patent_app_type] => utility
[patent_app_number] => 17/873485
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 40687
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17873485
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/873485 | Methods using novel CPF1 mutations that enhance the DNA cleavage activity of | Jul 25, 2022 | Issued |
Array
(
[id] => 20316140
[patent_doc_number] => 12454684
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Methods using novel CPF1 mutations that enhance the DNA cleavage activity of
[patent_app_type] => utility
[patent_app_number] => 17/873485
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 40687
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17873485
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/873485 | Methods using novel CPF1 mutations that enhance the DNA cleavage activity of | Jul 25, 2022 | Issued |
Array
(
[id] => 18005367
[patent_doc_number] => 20220364133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => Carbohydrate Binding Module Variants And Polynucleotides Encoding Same
[patent_app_type] => utility
[patent_app_number] => 17/812259
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812259
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812259 | Carbohydrate binding module variants and hybrid polypeptides comprising same | Jul 12, 2022 | Issued |
Array
(
[id] => 20372681
[patent_doc_number] => 12480107
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Lipase variants and the use thereof
[patent_app_type] => utility
[patent_app_number] => 17/716624
[patent_app_country] => US
[patent_app_date] => 2022-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61545
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716624
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/716624 | Lipase variants and the use thereof | Jul 5, 2022 | Issued |
Array
(
[id] => 20187277
[patent_doc_number] => 12398384
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => DNA modifying enzymes and active fragments and variants thereof and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/851880
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58200
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851880
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/851880 | DNA modifying enzymes and active fragments and variants thereof and methods of use | Jun 27, 2022 | Issued |
Array
(
[id] => 19464519
[patent_doc_number] => 20240318188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => BACILLUS LICHENIFORMIS HOST CELL FOR PRODUCTION OF A COMPOUND OF INTEREST WITH INCREASED PURITY
[patent_app_type] => utility
[patent_app_number] => 18/572827
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18572827
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/572827 | BACILLUS LICHENIFORMIS HOST CELL FOR PRODUCTION OF A COMPOUND OF INTEREST WITH INCREASED PURITY | Jun 23, 2022 | Pending |
Array
(
[id] => 17946073
[patent_doc_number] => 20220333090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => MODIFIED CAS9 PROTEIN AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/849581
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17849581
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/849581 | Polynucleotide encoding modified CAS9 protein | Jun 23, 2022 | Issued |
Array
(
[id] => 18212201
[patent_doc_number] => 20230058465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => Compositions And Methods For Production Of Salidroside, Icariside D2, And Precursors Of Salidroside And Icariside D2
[patent_app_type] => utility
[patent_app_number] => 17/847313
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17847313
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/847313 | Compositions and methods for production of salidroside, icariside D2, and precursors of salidroside and icariside D2 | Jun 22, 2022 | Issued |
Array
(
[id] => 19910453
[patent_doc_number] => 12286654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => Base editing enzymes
[patent_app_type] => utility
[patent_app_number] => 17/841082
[patent_app_country] => US
[patent_app_date] => 2022-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 26
[patent_no_of_words] => 22835
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17841082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/841082 | Base editing enzymes | Jun 14, 2022 | Issued |
Array
(
[id] => 18093506
[patent_doc_number] => 20220411847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => GLUCOSE/GALACTOSE BIOSENSORS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/833763
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833763
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/833763 | GLUCOSE/GALACTOSE BIOSENSORS AND METHODS OF USING SAME | Jun 5, 2022 | Abandoned |
Array
(
[id] => 18020953
[patent_doc_number] => 20220372452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => BIOCATALYSTS AND METHODS FOR THE SYNTHESIS OF ARMODAFINIL
[patent_app_type] => utility
[patent_app_number] => 17/833788
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31800
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833788
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/833788 | Biocatalysts and methods for the synthesis of armodafinil | Jun 5, 2022 | Issued |
Array
(
[id] => 18666156
[patent_doc_number] => 11773033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Bacterial consortia for enhancing conversion of organic soil phosphorous to orthophosphate and methods for making and using same
[patent_app_type] => utility
[patent_app_number] => 17/833492
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 35
[patent_no_of_words] => 11884
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833492
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/833492 | Bacterial consortia for enhancing conversion of organic soil phosphorous to orthophosphate and methods for making and using same | Jun 5, 2022 | Issued |
Array
(
[id] => 19432517
[patent_doc_number] => 20240301015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => SILK POLYPEPTIDE FORMULATION COMPRISING FORMATE
[patent_app_type] => utility
[patent_app_number] => 18/568183
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18568183
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/568183 | SILK POLYPEPTIDE FORMULATION COMPRISING FORMATE | Jun 1, 2022 | Pending |
Array
(
[id] => 17913566
[patent_doc_number] => 20220315961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/830650
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17830650
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/830650 | Engineered imine reductases and methods for the reductive amination of ketone and amine compounds | Jun 1, 2022 | Issued |
Array
(
[id] => 18148726
[patent_doc_number] => 20230022583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => ADIPATE (ESTER OR THIOESTER) SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 17/831011
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831011
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/831011 | ADIPATE (ESTER OR THIOESTER) SYNTHESIS | Jun 1, 2022 | Abandoned |
Array
(
[id] => 19318620
[patent_doc_number] => 20240240163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => TAQ-NEQSSB POLYMERASE, THE METHOD OF ITS OBTAINING, RECOMBINANT PLASMID, PRIMERS, AND APPLICATION OF THE POLYMERASE
[patent_app_type] => utility
[patent_app_number] => 18/562014
[patent_app_country] => US
[patent_app_date] => 2022-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4418
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562014
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/562014 | TAQ-NEQSSB POLYMERASE, THE METHOD OF ITS OBTAINING, RECOMBINANT PLASMID, PRIMERS, AND APPLICATION OF THE POLYMERASE | May 17, 2022 | Pending |
Array
(
[id] => 18229777
[patent_doc_number] => 20230068771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => EFFECTOR PROTEINS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/746851
[patent_app_country] => US
[patent_app_date] => 2022-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 163944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17746851
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/746851 | Effector proteins and methods of use | May 16, 2022 | Issued |
Array
(
[id] => 17960309
[patent_doc_number] => 20220340889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/745630
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745630
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745630 | Genetically engineered cells | May 15, 2022 | Issued |
Array
(
[id] => 17852194
[patent_doc_number] => 20220282236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => CREATININE DEIMINASE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/734169
[patent_app_country] => US
[patent_app_date] => 2022-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15325
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17734169
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/734169 | CREATININE DEIMINASE AND USES THEREOF | May 1, 2022 | Abandoned |
Array
(
[id] => 19572212
[patent_doc_number] => 20240376504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => ENZYMATIC SYNTHESIS OF MYCOSPORINE-LIKE AMINO ACIDS
[patent_app_type] => utility
[patent_app_number] => 18/286046
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -75
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18286046
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/286046 | ENZYMATIC SYNTHESIS OF MYCOSPORINE-LIKE AMINO ACIDS | Apr 7, 2022 | Pending |